Free Trial

Envista (NVST) Stock Price, News & Analysis

$16.41
0.00 (0.00%)
(As of 07/8/2024 ET)
Today's Range
$16.18
$16.73
50-Day Range
$16.00
$19.81
52-Week Range
$15.92
$36.14
Volume
2.56 million shs
Average Volume
2.59 million shs
Market Capitalization
$2.82 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.86

Envista MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
51.5% Upside
$24.86 Price Target
Short Interest
Healthy
5.18% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.92
Upright™ Environmental Score
News Sentiment
0.51mentions of Envista in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
14.17%
From $1.20 to $1.37 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.47 out of 5 stars

Medical Sector

121st out of 876 stocks

Dental Equipment & Supplies Industry

2nd out of 3 stocks

NVST stock logo

About Envista Stock (NYSE:NVST)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Stock Price History

NVST Stock News Headlines

[Urgent!] Generational Wealth Gameplan
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Tracking Tweedy Browne Portfolio - Q1 2024 Update
[Urgent!] Generational Wealth Gameplan
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Goldman Sachs Keeps Their Sell Rating on Envista Holdings (NVST)
Unveiling 4 Analyst Insights On Envista Holdings
Envista Reports First Quarter 2024 Results
See More Headlines
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/01/2024
Today
7/09/2024
Next Earnings (Estimated)
8/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Employees
12,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.86
High Stock Price Target
$45.00
Low Stock Price Target
$17.50
Potential Upside/Downside
+51.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
13 Analysts

Profitability

Net Income
$-100,200,000.00
Pretax Margin
-2.94%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$2.54 per share
Book Value
$24.35 per share

Miscellaneous

Free Float
169,624,000
Market Cap
$2.82 billion
Optionable
Optionable
Beta
1.31
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

NVST Stock Analysis - Frequently Asked Questions

How have NVST shares performed this year?

Envista's stock was trading at $24.06 at the beginning of the year. Since then, NVST shares have decreased by 31.8% and is now trading at $16.41.
View the best growth stocks for 2024 here
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) posted its earnings results on Wednesday, May, 1st. The company reported $0.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.31 by $0.05. Envista's revenue was down .6% compared to the same quarter last year.

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

Envista (NVST) raised $603 million in an initial public offering (IPO) on Wednesday, September 18th 2019. The company issued 26,800,000 shares at a price of $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Who are Envista's major shareholders?

Top institutional shareholders of Envista include Versant Capital Management Inc. Insiders that own company stock include Amir Aghdaei, Eric Conley, Howard H Yu, Mark E Nance, Stephen Keller, Mischa Reis, Jeffrey Kappler and Curt W Bludworth.
View institutional ownership trends
.

How do I buy shares of Envista?

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NVST) was last updated on 7/9/2024 by MarketBeat.com Staff

From Our Partners